Clinical Outcomes of Drug-Coated Balloons in Coronary Artery Disease Unsuitable for Drug-Eluting Stent Implantation.
PMID:
Two-year clinical outcome after abciximab-coated stent implantation in patients with coronary artery disease.
PMID:
Randomized comparative study of diamond-like carbon coated stainless steel stent versus uncoated stent implantation in patients with coronary artery disease.
PMID:
Drug-Coated Balloons in the Management of Coronary Artery Disease.
Sirolimus-coated balloon versus everolimus-eluting stent in de novo coronary artery disease: Rationale and design of the TRANSFORM II randomized clinical trial.
Greco A, Sciahbasi A, Abizaid A, Mehran R, Rigattieri S, de la Torre Hernandez JM, Alfonso F, Cortese B.
Coronary Artery Dissection in Drug-Coated Balloon Angioplasty: Incidence, Predictors, and Clinical Outcomes.
Gitto M, Leone PP, Gioia F, Chiarito M, Latini A, Tartaglia F, Kilic ID, Rossi ML, Regazzoli D, Gasparini G, Cozzi O, Sticchi A, Condorelli G, Reimers B, Stefanini G, Mangieri A, Colombo A.
Am J Cardiol. 2025 Mar 15;239:28-35. doi: 10.1016/j.amjcard.2024.12.008. Epub 2024 Dec 10.
PMID:39667516
Vascular healing in high-bleeding-risk patients at 3-month after everolimus-eluting stent versus biolimus A9-coated stent implantation: insights from analysis of optical coherence tomography and coronary angioscopy.
Koiwaya H, Nishihira K, Kadooka K, Kuriyama N, Shibata Y.